{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:23Z","timestamp":1789506623440,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpeds.2026.115213","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:30:19Z","timestamp":1782948619000},"page":"115213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Children in the Vaccine Adverse Event Reporting System"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-0411","authenticated-orcid":false,"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Head","family":"Zauche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Stroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2026.115213_bib1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2026.115213_bib2","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpeds.2026.115213_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.15585\/mmwr.mm7137a3","article-title":"Use of 15-valent pneumococcal conjugate vaccine among US children: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2026.115213_bib6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.15585\/mmwr.mm7239a5","article-title":"ACIP updates: recommendations for use of 20-valent pneumococcal conjugate vaccine in children\u2014United States, 2023","volume":"72","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2026.115213_bib7","series-title":"20-valent pneumococcal conjugate vaccine safety and immunogenicity study of a 4-dose series in healthy infants","year":"2020"},{"key":"10.1016\/j.jpeds.2026.115213_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/INF.0000000000003277","article-title":"Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy infants in the United States","volume":"40","author":"Senders","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2026.115213_bib9","series-title":"Safety and immunogenicity study of 20vPnC in healthy children 15 months through 17 years of age","year":"2020"},{"key":"10.1016\/j.jpeds.2026.115213_bib10","series-title":"20-valent pneumococcal conjugate vaccine safety study in healthy infants","year":"2020"},{"key":"10.1016\/j.jpeds.2026.115213_bib11","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib12","unstructured":"National Childhood Vaccine Injury Act of 1986. 42 USC \u00a7\u00a7300aa-1 to 300aa-34."},{"key":"10.1016\/j.jpeds.2026.115213_bib15","first-page":"52252","article-title":"Postmarketing reporting of adverse experiences","volume":"62","year":"1997","journal-title":"Fed Regist"},{"key":"10.1016\/j.jpeds.2026.115213_bib16","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.vaccine.2013.03.040","article-title":"Postlicensure surveillance for prespecified adverse events following the 13-valent pneumococcal conjugate vaccine in children","volume":"31","author":"Tseng","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib17","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","article-title":"Anaphylaxis: revision of the Brighton Collaboration case definition","volume":"41","author":"Gold","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.vaccine.2003.09.008","article-title":"Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.vaccine.2003.09.009","article-title":"Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib20","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1016\/j.vaccine.2016.09.025","article-title":"Kawasaki disease and immunization: standardized case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Phuong","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"10.1016\/j.jpeds.2026.115213_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpeds.2026.115213_bib23","unstructured":"45 CFR part 46; 21 CFR part 56; 42 USC \u00a7241(d); 5 USC \u00a7552a; 44 USC \u00a73501 et seq."},{"key":"10.1016\/j.jpeds.2026.115213_bib24","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.jpeds.2026.115213_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pediatrneurol.2017.08.005","article-title":"Febrile seizure risk after vaccination in children one to five months of age","volume":"76","author":"Duffy","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2026.115213_bib26","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.vaccine.2011.12.042","article-title":"Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the Vaccine Adverse Event Reporting System","volume":"30","author":"Leroy","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2026.115213_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/INF.0000000000003308","article-title":"Hypotonic-hyporesponsive episodes after diphtheria, tetanus, and acellular pertussis vaccination","volume":"40","author":"Hansen","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2026.115213_bib28","first-page":"523","article-title":"Incidence of hypotonic-hyporesponsive episodes associated with the combined DTP\/Hib vaccine used in the Brazilian National Immunization Program","volume":"83","author":"Martins","year":"2007","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.jpeds.2026.115213_bib29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-058789","article-title":"Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines","volume":"150","author":"Kamidani","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.115213_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in US infants","volume":"370","author":"Yih","year":"2014","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.jpeds.2026.115213_bib31","article-title":"Preliminary results of 20-valent pneumococcal conjugate vaccine (PCV20) monitoring in children through 24 months of age in the Vaccine Safety Datalink","volume":"13","author":"Kenigsberg","year":"2026","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jpeds.2026.115213_bib32","series-title":"Mortality in the United States, 2023. NCHS Data Brief No. 521","author":"Murphy","year":"2024"},{"key":"10.1016\/j.jpeds.2026.115213_bib33","series-title":"Immunization safety review: vaccinations and sudden unexpected death in infancy","year":"2003"},{"key":"10.1016\/j.jpeds.2026.115213_bib35","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626002416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626002416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:32:32Z","timestamp":1789504352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347626002416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S0022347626002416"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115213","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Children in the Vaccine Adverse Event Reporting System","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115213"}}